Literature DB >> 16708020

GPR39 receptor expression in the mouse brain.

Valerie R Jackson1, Hans-Peter Nothacker, Olivier Civelli.   

Abstract

GPR39, an orphan G protein-coupled receptor, has been recently identified as the receptor for the bioactive peptide obestatin. Obestatin is secreted from the stomach and acts as an anti-appetite hormone. This activity is induced whether obestatin is administered intraperitoneally or intracerebroventricularly. GPR39 is known to be expressed in the central nervous system but its precise localization is unknown. In view of the growing importance of this system, we decided to study the sites of GPR39 mRNA expression by in-situ hybridization. We find the highest levels of GPR39 mRNA in the amygdala, the hippocampus, and the auditory cortex and low levels in several other brain regions. Surprisingly, we find no expression of GPR39 in the hypothalamus, expected to be the site of the anorexigenic action of obestatin.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16708020     DOI: 10.1097/01.wnr.0000215779.76602.93

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  23 in total

Review 1.  GPR39: a Zn(2+)-activated G protein-coupled receptor that regulates pancreatic, gastrointestinal and neuronal functions.

Authors:  Petra Popovics; Alan J Stewart
Journal:  Cell Mol Life Sci       Date:  2010-09-02       Impact factor: 9.261

Review 2.  Obesity, gut hormones, and bariatric surgery.

Authors:  Dimitrios J Pournaras; Carel W le Roux
Journal:  World J Surg       Date:  2009-10       Impact factor: 3.352

3.  Homeostatic regulation of KCC2 activity by the zinc receptor mZnR/GPR39 during seizures.

Authors:  David Gilad; Sharon Shorer; Maya Ketzef; Alon Friedman; Israel Sekler; Elias Aizenman; Michal Hershfinkel
Journal:  Neurobiol Dis       Date:  2015-01-03       Impact factor: 5.996

Review 4.  Neuro-psychopharmacological perspective of Orphan receptors of Rhodopsin (class A) family of G protein-coupled receptors.

Authors:  Muhammad Zahid Khan; Ling He
Journal:  Psychopharmacology (Berl)       Date:  2017-03-13       Impact factor: 4.530

5.  Central obestatin administration does not modify either spontaneous or ghrelin-induced food intake in rats.

Authors:  L M Seoane; O Al-Massadi; Y Pazos; U Pagotto; F F Casanueva
Journal:  J Endocrinol Invest       Date:  2006-09       Impact factor: 4.256

Review 6.  Biological effects of obestatin.

Authors:  Jiang-Bo Li; Akihiro Asakawa; Kaichun Cheng; Yingxiao Li; Huhe Chaolu; Minglun Tsai; Akio Inui
Journal:  Endocrine       Date:  2011-03-20       Impact factor: 3.633

7.  Influence of short- and long-term treadmill exercises on levels of ghrelin, obestatin and NPY in plasma and brain extraction of obese rats.

Authors:  Jun Wang; Chen Chen; Rui-Yuan Wang
Journal:  Endocrine       Date:  2008-04-04       Impact factor: 3.633

8.  Peripheral obestatin has no effect on feeding behavior and brain Fos expression in rodents.

Authors:  Peter Kobelt; Anna-Sophia Wisser; Andreas Stengel; Miriam Goebel; Norbert Bannert; Guillaume Gourcerol; Tobias Inhoff; Steffen Noetzel; Bertram Wiedenmann; Burghard F Klapp; Yvette Taché; Hubert Mönnikes
Journal:  Peptides       Date:  2008-02-07       Impact factor: 3.750

9.  Synaptic Zn2+ inhibits neurotransmitter release by promoting endocannabinoid synthesis.

Authors:  Tamara Perez-Rosello; Charles T Anderson; Francisco J Schopfer; Yanjun Zhao; David Gilad; Sonia R Salvatore; Bruce A Freeman; Michal Hershfinkel; Elias Aizenman; Thanos Tzounopoulos
Journal:  J Neurosci       Date:  2013-05-29       Impact factor: 6.167

10.  Synaptically released zinc triggers metabotropic signaling via a zinc-sensing receptor in the hippocampus.

Authors:  Limor Besser; Ehud Chorin; Israel Sekler; William F Silverman; Stan Atkin; James T Russell; Michal Hershfinkel
Journal:  J Neurosci       Date:  2009-03-04       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.